Instil Bio, Inc.

NASDAQ:TIL

Biotechnology

Healthcare
$7.45 +0.13%

+$0.01 today

Market cap
$50.53M
Beta
1.91
P/E (TTM)
-1.1
EPS (TTM)
-$6.99
52W Low $5.67High $33.83

Volume 0.02M

Average 0.03M

TIL Short-term Investments

Marketable securities and deposits the company expects to convert to cash within a year.

Instil Bio, Inc.NASDAQ: TIL

Short-term Investments · Q1 FY2026 · quarter ended Mar 2026

Short-term investments falls 21.2% from a year ago

Short-term investments stood at $69.55M at the end of Q1 FY2026, down 21.2% from a year earlier and up 0.1% from the prior quarter. Over 3 fiscal years it compounded at -31.6% a year.

Context

  • Short-term investments amounted to 34.7% of total assets at the end of Q1 FY2026, down 2.5 pp from a year earlier.
  • Short-term investments increased in 0 of the last 3 fiscal years.
  • FY2025 was the lowest annual figure in the 4 fiscal years shown.

What to watch

Whether short-term investments keeps falling in the next quarterly balance sheet after a -21.2% change from a year earlier.

Sources:Balance SheetText generated from reported figures; not investment advice.

Latest quarterMar 2026
$69.55M+0.1% QoQ
Last fiscal yearDec 2025
$69.49M-33.5% YoY
Year agoMar 2025
$88.29M-21.2% since
Short-term Investments past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-21.2%——
1 year-33.5%——
3-year CAGR-31.6%——
5-year CAGR——
10-year CAGR——

Short-term Investments history

USD · from the balance sheet

Latest · FY2025
69.49M USD
Year-over-year change
-33.5%
4-year CAGR
-36.1%

Short-term Investments vs competitors

How TIL compares with its peers on the latest reported figures

  • Peers report in different currencies, so short-term investments is compared through growth and share of total assets rather than absolute size.
  • Its year-over-year change of -21.2% is the 4th highest of 6, against a peer median of +33.7%.
  • Short-term investments amounts to 34.7% of total assets for TIL, versus a peer median of 45.5%.
TIL Competitors
Short-term Investments for TIL and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
ZNTLZentalis Pharmaceuticals, Inc.Mar 2026$179.83M USD-38.1%-19.0%71.1%
PLRXPliant Therapeutics, Inc.Mar 2026$148.7M USD-30.4%-21.2%73.4%
WHWKWhitehawk Therapeutics IncMar 2026$88.25M USD+2426.6%-6.8%69.4%
MGNXMacroGenics, Inc.Mar 2026$87.71M USD+923.4%+42.9%40.3%
TILInstil Bio, Inc.Mar 2026$69.55M USD-21.2%-31.6%34.7%
IFRXInflaRx N.V.Mar 2026€24.83M EUR+33.7%-22.6%50.7%
STTKShattuck Labs, Inc.Mar 2026$0 USD—-40.6%0.0%
SRZNSurrozen, Inc.Mar 2026$0 USD——0.0%
ONCYOncolytics Biotech Inc.Mar 2026CA$0 CAD——0.0%
Peer median (excluding TIL) —+33.7%-20.1%45.5%

Competitors are the stored peer set for TIL. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents37.59M43.72M9.2M8.81M6.64M
Short-term Investments416.51M217.2M141.16M104.51M69.49M
Net Receivables0000848K
Inventory00000
Other Current Assets08.46M1.5M1.83M112.41M
Total Current Assets464.02M269.38M160.76M124.47M191.43M
Property, Plant & Equipment (Net)122M209.34M141.07M130.34M364K
Goodwill5.72M0000
Intangible Assets10.1M0000
Long-term Investments0023.16M00
Tax Assets00000
Other Non-current Assets8.14M3.41M639K8.76M11.73M
Total Non-current Assets145.96M212.75M164.87M139.1M12.09M
Total Assets609.98M482.13M325.63M263.57M203.52M
Account Payables5.57M2.36M1.21M659K779K
Short-term Debt00000
Tax Payables524K0000
Deferred Revenue00000
Other Current Liabilities13.66M4.23M1.22M2.07M2.52M
Total Current Liabilities41.36M32.79M10.56M7.9M4.84M
Long-term Debt072.35M81.43M84.19M84.81M
Deferred Tax Liabilities2.43M0000
Deferred Revenue (Non-current)00000
Other Non-current Liabilities11M8.21M4.94M1.03M8K
Total Non-current Liabilities13.43M85.74M89.24M86.24M84.81M
Total Liabilities54.78M118.52M99.8M94.13M89.66M
Common Stock00000
Retained Earnings(201.72M)(424.89M)(580.98M)(655.12M)(726.49M)
Accumulated OCI(87K)(493K)(348K)(228K)(583K)
Other Stockholders Equity000(0)0
Minority Interest00000
Total Equity555.2M363.61M225.83M169.44M113.87M
Total Debt079.9M86.05M86.89M85.18M
Net Debt(37.59M)36.19M76.86M78.08M78.54M

Instil Bio, Inc.

NASDAQ:TIL

Intrinsic Alpha fair value

Locked

Current Price

$7.45

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.